Phase Weeks 1-2 Draw volume 7.5 units (0.075 mL) Total blend delivered ~2.0 mg total blend GHK-Cu ~1.25 mg KPV ~250 mcg BPC-157 ~250 mcg TB-500 ~250 mcg Phase Weeks 3-4 Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Phase Weeks 5-8 Draw volume 22.5 units (0.225 mL) Total blend delivered ~6.0 mg total blend GHK-Cu ~3.75 mg KPV ~750 mcg BPC-157 ~750 mcg TB-500 ~750 mcg Phase Weeks 9-12 (taper) Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Blend ratio 50 / 10 / 10 / 10 mg GHK-Cu dominant Select a draw volume from the titration table above to see the approximate amount of each peptide delivered
Vicariotto F, Malfa P, Torricelli M, Lungaro L, Caio G, De Leo V
Research has examined Ipamorelins effects on bone mineral density, osteocalcin and bone-specific alkaline phosphatase markers, and growth plate chondrocyte biology in rodent models
Additional well-powered randomized controlled trials are needed to better understand the impact of exercise on histological and clinical endpoints in NAFLD
The comparative reasoning is expanded in the DAC vs no-DAC protocol comparison
Amount Per Serving: Opitac L-Glutathione 100 mg ( %DV not established)